A transcriptome analysis by lasso penalized Cox regression for pancreatic cancer survival.

Pancreatic cancer is the fourth leading cause of cancer deaths in the United States with five-year survival rates less than 5% due to rare detection in early stages. Identification of genes that are directly correlated to pancreatic cancer survival is crucial for pancreatic cancer diagnostics and treatment. However, no existing GWAS or transcriptome studies are available for addressing this problem. We apply lasso penalized Cox regression to a transcriptome study to identify genes that are directly related to pancreatic cancer survival. This method is capable of handling the right censoring effect of survival times and the ultrahigh dimensionality of genetic data. A cyclic coordinate descent algorithm is employed to rapidly select the most relevant genes and eliminate the irrelevant ones. Twelve genes have been identified and verified to be directly correlated to pancreatic cancer survival time and can be used for the prediction of future patient's survival.

[1]  Shuang-yin Han,et al.  Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27Kip1 , 2009, Journal of cellular and molecular medicine.

[2]  C. Pilarsky,et al.  The Role of Apoptosis in the Pathology of Pancreatic Cancer , 2010, Cancers.

[3]  Yanghua Xiao,et al.  Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma , 2010, BMC Systems Biology.

[4]  W. Bamlet,et al.  Obesity adversely affects survival in pancreatic cancer patients , 2010, Cancer.

[5]  Judy M. Anderson,et al.  A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma , 2010, PLoS medicine.

[6]  G. Castellano,et al.  Tumor and Stem Cell Biology Cancer Research Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells , 2010 .

[7]  Udaya B. Kogalur,et al.  High-Dimensional Variable Selection for Survival Data , 2010 .

[8]  Hyeyoung Kim,et al.  Altered gene expression in cerulein-stimulated pancreatic acinar cells: pathologic mechanism of acute pancreatitis. , 2009, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[9]  S. Ortega,et al.  Increased Susceptibility to Skin Carcinogenesis in TREX2 Knockout Mice. , 2009, Cancer research.

[10]  G. Rodríguez-Tarduchy,et al.  1H HR‐MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas , 2009, NMR in biomedicine.

[11]  E. Åvall-Lundqvist,et al.  Ovarian carcinoma cells with low levels of β-F1-ATPase are sensitive to combined platinum and 2-deoxy-d-glucose treatment , 2009, Molecular Cancer Therapeutics.

[12]  Insuk Sohn,et al.  Gradient lasso for Cox proportional hazards model , 2009, Bioinform..

[13]  Trevor J. Hastie,et al.  Genome-wide association analysis by lasso penalized logistic regression , 2009, Bioinform..

[14]  Robert J Tibshirani,et al.  Statistical Applications in Genetics and Molecular Biology , 2011 .

[15]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[16]  Karl J. Dykema,et al.  Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated ELGN2-Mediated Oxygen-Sensing Response , 2008, PLoS genetics.

[17]  R. Buchert,et al.  Gene Expression Patterns and Tumor Uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an Orthotopic Mouse Xenotransplantation Model of Pancreatic Cancer , 2008, Journal of Nuclear Medicine.

[18]  David Goldstein,et al.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells. , 2008, Cancer research.

[19]  K. Lange,et al.  Coordinate descent algorithms for lasso penalized regression , 2008, 0803.3876.

[20]  S. Seneca,et al.  Development of a human mitochondrial oligonucleotide microarray (h-MitoArray) and gene expression analysis of fibroblast cell lines from 13 patients with isolated F1Fo ATP synthase deficiency , 2008, BMC Genomics.

[21]  Jens Pietzsch,et al.  L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-l-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo , 2007, Journal of Nuclear Medicine.

[22]  K. Coombes,et al.  Zonal heterogeneity for gene expression in human pancreatic carcinoma. , 2007, Cancer research.

[23]  R. Tibshirani,et al.  PATHWISE COORDINATE OPTIMIZATION , 2007, 0708.1485.

[24]  P. Hasty,et al.  Biochemical and cellular characteristics of the 3′ → 5′ exonuclease TREX2 , 2007, Nucleic acids research.

[25]  Jian Huang,et al.  Additive risk survival model with microarray data , 2007, BMC Bioinformatics.

[26]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[27]  H. Lage,et al.  Transcriptome analysis of different multidrug-resistant gastric carcinoma cells. , 2005, In vivo.

[28]  M. Palacín,et al.  Identification of LAT4, a Novel Amino Acid Transporter with System L Activity* , 2005, Journal of Biological Chemistry.

[29]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[30]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[31]  Z. Bhujwalla,et al.  Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline. , 2004, Molecular imaging.

[32]  David E. Misek,et al.  The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. , 2004, Carcinogenesis.

[33]  Yumei Zhang,et al.  Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. , 2004, Experimental cell research.

[34]  W. Park,et al.  Somatic mutations of CASP3 gene in human cancers , 2004, Human Genetics.

[35]  P. Muscarella,et al.  The genetics of pancreatic cancer. , 2003, American journal of surgery.

[36]  G. Nash,et al.  Pancreatic acinar cell carcinoma presenting as acute pancreatitis. , 2003, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[37]  M. W. Büchler,et al.  Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer , 2003, Cellular and Molecular Life Sciences CMLS.

[38]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[39]  John C Reed,et al.  The bioenergetic signature of cancer: a marker of tumor progression. , 2002, Cancer research.

[40]  H. Degani,et al.  Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. , 2002, Cancer research.

[41]  P. Tseng.  Convergence of a Block Coordinate Descent Method for Nondifferentiable Minimization , 2001 .

[42]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Wallace,et al.  A mitochondrial paradigm for degenerative diseases and ageing. , 2001, Novartis Foundation symposium.

[44]  Dan J. Mazur,et al.  Identification and Expression of the TREX1 and TREX2 cDNA Sequences Encoding Mammalian 3′→5′ Exonucleases* , 1999, The Journal of Biological Chemistry.

[45]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[46]  J. Niederhuber,et al.  The national cancer data base report on pancreatic cancer , 1995, Cancer.

[47]  M. Denis,et al.  Over‐expression of the S13 ribosomal protein in actively growing cells , 1993, International journal of cancer.

[48]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[49]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .